FDA warns China’s Hangzhou Yiqi Biotechnology Co. about CGMP deviations in its manufacturing of active pharmaceutical ingredients.
Medical Devices
TEMPO Digital Health Pilot FAQs
FDA publishes frequently asked questions covering eligibility, statement of interest, and selection of participants for the TEMPO digital health pilot project being run with the Center for Medicare and Medicaid Innovation.
